Emcure Pharma’s successful debut impressed investors and analysts on the stock exchange, reflecting strong confidence in the company’s growth prospects and management team. The premium opening price of Rs. 1325.05 indicated strong demand for the stock, with investors eager to capitalize on Emcure Pharma’s potential in the pharmaceutical industry. This strong outlook for the stock …
Crizac Ltd., a student recruitment solution provider based in Kolkata, has encountered a significant hurdle in its plans to launch a Rs 1,000-crore initial public offering (IPO). The Securities and Exchange Board of India (SEBI) has returned the draft documents, causing a delay in the company’s initial share sale. This IPO was intended to be …
Stallion India Fluorochemicals has received the green light from the Securities and Exchange Board of India (SEBI) to raise capital through an initial public offering (IPO). The company plans to issue new equity shares and conduct an offer-for-sale, as detailed in their draft red herring prospectus. IPO Details and Allocation of Funds Stallion India Fluorochemicals …
Introduction In a significant development for the Indian stock market, the National Stock Exchange of India Limited (NSE) has achieved a landmark with the listing of its 500th SME company on the NSE EMERGE platform. This milestone highlights the growing importance and success of SME companies in India’s economic landscape. The 500th Listing: Prizor Viztech …
Sai Life Science Ltd., a Hyderabad-based global pharmaceutical company backed by TPG Group, has filed preliminary papers with the Securities and Exchange Board of India (SEBI) for an initial public offering (IPO). This significant step will help the company raise funds to support its growth and operational needs. IPO Details and Shareholder Information Sai Life …
In October 2022, the Reserve Bank of India (RBI) mandated that Non-Banking Financial Companies (NBFCs) belonging to the upper layer (UL) of the system should be listed publicly on the exchange by the end of September 2025. As a result, we have observed HDFC Bank Ltd., one of India’s largest private sector banks, taking steps …
Today, on the last day of the bidding process, Emcure Pharmaceuticals Limited IPO was subscribed 67.84 times. The retail portion was subscribed to 7.33x, 191.24x in Qualified Institutional Buyers (QIB), 49.28x in Non-Institutional Investors (NII), and 8.78x in the employees category. Here’s a table to understand the day-wise subscription Date QIB NII Retail EMP Total …
Emcure Pharmaceuticals Limited, an Indian firm, that specializes in the development, manufacturing, and worldwide distribution of a diverse range of pharmaceutical products spanning multiple key therapeutic categories, debuted on the Indian stock market today. The company’s stock settled at Rs 1325.05 per share on the BSE, representing an impressive 31.45% premium over the final issue …
Burger King IPO launch receiving massive oversubscription exhibits investors’ strong faith in the market recovery. Burger King IPO is the fourteenth IPO to launch 2020, and the third to receive overwhelming 150 times subscription. The year overall proved to be a strong one for the primary market where companies have already raised Rs 30000 crores …
Today, on the second day of the bidding process, Emcure Pharmaceuticals Limited IPO was subscribed 4.98 times. The retail portion was subscribed to 3.50x, 0.97x in Qualified Institutional Buyers (QIB), 13.95x in Non-Institutional Investors (NII), and 4.84x in the employees category. On the first day, the IPO saw an overall subscription of 1.34 times. The …
